INTRODUCTION
At the early stages of embryonic development, the multipotent epiblast gives rise to the three germ layers which are subsequently specified to form all tissues of the developing organism (Tam and Loebel, 2007) . The initiation of germ layer formation occurs through a process known as gastrulation in which cells from the epiblast undergo an epithelial to mesenchymal transition and ingress through the primitive streak to generate mesoderm and endoderm (Tam and Behringer, 1997) . Cells exiting the posterior part of the primitive streak give rise to the extra-embryonic and lateral plate mesoderm. In gastrulating embryos, the extra-embryonic mesoderm contributes to the formation of the yolk sac blood islands (Palis et al., 1995) , the allantois, the amnion, the chorion and the mesothelium lining of the exocoelomic cavity (Tam et al., 1997) . Fusion of the allantois and chorion later establishes the connection between the placenta and the embryo, forming the umbilical cord (Downs, 1998) . Endothelial and smooth muscle lineages forming the vasculature and both the endocardium and myocardium of the heart are also derived from the mesoderm emerging from the posterior primitive streak (Kinder et al., 2001; Kinder et al., 1999) . Some of these early events of embryonic development can be recapitulated in vitro upon the differentiation of pluripotent embryonic stem cells (ESCs) , providing an alternative model system to the in vivo settings for the study of cell fate specification during development (Keller, 2005; Lacaud et al., 2004) . The molecular mechanisms controlling the specification of mesoderm are starting to be unravelled but the overall transcriptional network orchestrating this process is still poorly understood. In particular, how alternate cell fates are regulated in nascent mesoderm is mostly unknown.
The specification of blood and endothelial lineages is tightly associated, depending on similar signalling pathways and transcription factors for their emergence (Costa et al., 2012a;  Development Accepted manuscript Moignard et al., 2013) . Soon after gastrulation, the hemangioblast, found within the primitive streak, gives rise to blood precursors through a specific population of endothelial cells with hemogenic properties, i.e. the hemogenic endothelium (Eilken et al., 2009; Huber et al., 2004; Lancrin et al., 2009b) . While it is clear that not all endothelial cells are derived from hemangioblast precursors, it is still not understood how a specific subset of mesoderm becomes committed to the hematopoietic fate. The FLK1-VEGF signalling axis and the ETS transcription factor ETV2 have been shown to be essential very early in mesoderm for the generation of both endothelial and hematopoietic lineages (Kataoka et al., 2011; Lee et al., 2008; Shalaby et al., 1995; Wareing et al., 2012b) . However, both FLK1 and ETV2 are widely expressed in nascent mesoderm and are unlikely to be responsible for restricting mesoderm specification to blood and/or endothelium fate. Directly regulated by ETV2, the bHLH transcription factor SCL is required for both primitive and definitive hematopoiesis through its control of hemogenic endothelium formation (Lancrin et al., 2009b; Porcher et al., 1996; Wareing et al., 2012b) . Specification to the cardiac tissues was shown to depend on a distinct set of transcriptional regulators. The heart is composed of several lineages, including cardiomyocytes, endothelial and smooth muscle cells and is formed by two sources of progenitors derived from the first heart field formed by the cardiac crescent and the second heart fields derived from pharyngeal mesoderm (Olson, 2006) . The transcription factor MESP1, a master regulator of cardiac development is expressed in the primitive streak, and is the earliest marker of cardiogenesis (Saga et al., 1996; Saga et al., 2000) . Upon enforced expression, MESP1 promotes the generation of all cardiac lineages, controlling the downstream cascade of transcriptional regulators including NKX2.5, GATA4, HAND1/2 and MEF2C (Bondue et al., 2008; Lindsley et al., 2008) . In contrast, little is known about the specification of the mesoderm to the mesothelium that forms an epithelial monolayer lining the exocoelomic cavity in early embryos and all body cavities and organs later in life Development Accepted manuscript (Mutsaers, 2004) . Throughout development and in the adult organism, the mesothelium is implicated in the control of fluid and solute transport, in the regulation of inflammation and wound healing. Apart from its mesodermal origin, nothing is known about the molecular control underlying the specification of this lineage that shares a common mesodermal origin with the cardiovascular system. Overall, the molecular mechanism that regulates the allocation and patterning of extra-embryonic mesoderm to the various lineages of the cardiovascular system and mesothelium is still unknown. How MESP1, ETV2, SCL and other transcriptional regulators are integrated into a network activating or repressing cell fate decisions remains to be defined.
Forkhead box (FOX) transcription factors belong to an evolutionary conserved family of proteins named after the Drosophila forkhead gene whose mutation results in a spiked head phenotype. There are 44 FOX proteins in the mouse genome, all characterized by a forkhead DNA-binding motif, and assembled into 19 subgroups based on sequence homologies inside and outside the forkhead domain (Jackson et al., 2010) . FOX proteins are implicated in multiple key aspects of embryonic development and adult homeostasis ranging from proliferation, differentiation to metabolism and senescence. FOXF1, one of the two members of the FOXF subgroup, is widely expressed in extra-embryonic and lateral plate mesoderm (Kalinichenko et al., 2003; Mahlapuu et al., 2001b) and its deletion leads to early embryonic lethality with a complete absence of vasculogenesis and mis-expression of hematopoietic and vascular markers (Mahlapuu et al., 2001b) . The vasculogenesis defect can be restored to some level in explant cultures by BMP4 addition, indicating that the BMP signalling axis acts downstream of FOXF1 (Astorga and Carlsson, 2007) . At the late stage of embryonic development, heterozygosity or mutation in FOXF1 is linked to lung malformation and alveolar capillary dysplasia involving the abnormal development of the vascular capillary system in lungs (Kalinichenko et al., 2001; Mahlapuu et al., 2001a; Stankiewicz et al., 2009 ).
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Given its expression pattern and null phenotype, we became interested in the potential role of FOXF1 during mesoderm specification to the cardiovascular system. In order to precisely characterize its expression, to track and isolate FOXF1-expressing mesoderm, we generated ESCs and transgenic mouse lines carrying a foxf1-venus knock-in allele. In the present study, using both in vitro and in vivo systems, we investigated when and where FOXF1 is expressed at the early stages of mesoderm development and how FOXF1 expression might contribute to mesoderm specification during gastrulation.
RESULTS

FOXF1 expression is initiated within the early FLK1 + mesoderm population during in vitro differentiation
To track the expression of FOXF1 at the earliest stage of mesoderm commitment, we generated an ESC line carrying the H2B-VENUS reporter protein under the control of Foxf1 EBs and analyzed for the expression of genes known to be involved in lineage decisions during mesoderm differentiation. As shown in figure 2A , whilst as expected the expression of Foxf1 was enriched in the FOXF1::VENUS + population, the expression of genes involved in hemogenic endothelial specification (Scl, Gata2, Sox7) (Costa et al., 2012b; Pimanda et al., 2007) were enriched in the FOXF1::VENUS -population compared to FOXF1::VENUS + .
Similarly, genes involved in cardiac lineage cell fate decision (Nkx2.5 and Mesp1) (Chen and Fishman, 1996; Saga et al., 1999) were more predominantly expressed in the cell population negative for FOXF1 expression. We also assessed the hematopoietic output of these populations through differentiation in hemangioblast culture followed by flow cytometry and expression were detected in the mesothelium and allantois ( Fig. 4Ci-iii) .
Of interest, cells within the developing blood islands did not express detectable levels of FOXF1::VENUS (Fig. 4Ciii,iv (Fig. 2D) , we assessed in vivo the co-expression of FOXF1
and SMA during gastrulation. At the early headfold stage, SMA expression was mainly detected in the chorion where it overlapped with FOXF1::VENUS expression (Fig. 5i) . At the late headfold and early somite stage, SMA expression was now also observed in the mesothelium lining the exocoelomic cavity and the prospective heart field ( Fig. 5ii-iv) . At these stages, FOXF1::VENUS and SMA were clearly coexpressed in the mesothelium; a few SMA + FOXF1::VENUS low were also observed in the presumptive cardiac mesoderm (Fig 5iii-iv) . In the transcriptomic analysis, differentially expressed genes with 2-fold or more changes in expression levels between at least two of the sorted populations were clustered and submitted to Gene Ontology annotation to highlight enriched biological functions within each population (Fig. 6D , supplementary material Table S1 ). This analysis identified three (Fig. 6G) . No significant differences in lineage output were observed between the two FLK1 + populations (Fig. 6H) .
Similarly, all populations displayed endothelium potential as shown by CD144 staining ( 
FOXF1 expression impairs the hematopoietic potential of mesodermal precursors
To establish whether FOXF1 might participate in lineage choices during mesoderm differentiation, we generated an ESC line in which FOXF1 linked to the GFP reporter protein via a 2A peptide can be expressed upon doxycycline addition using a Tet-on inducible system
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(thereafter referred to as iFoxf1), as previously described (Gandillet et al., 2009; Kyba et al., 2002) . Upon EB differentiation, FLK1 + mesodermal cells were sorted and cultured in hemangioblast condition to allow differentiation to hematopoietic, endothelial and smooth muscle lineages (Stefanska et al., 2014) . The doxycycline-mediated induction of FOXF1 expression from day 0 or day 1 of the culture dramatically decreased the hematopoietic output as shown by flow cytometry analysis of CD41 and CD45 expression (Fig. 7A, upper panel), clonogenic replating assay (Fig. 7B ) and the absence of hemogenic endothelial clusters giving rise to hematopoietic cells (supplementary material Fig. S6A ) as previously shown in this culture system (Lancrin et al., 2009b) . Interestingly, this block in hematopoietic differentiation was irreversible as removal of doxycycline even after only 12 hours of induction was unable to restore the generation of hematopoietic cells (Fig. 7A, lower panel) .
Similar results were also obtained when the induction of FOXF1 expression was performed during EB culture with doxycycline added at day 3, 4 or 5 (supplementary material Fig. S6B ).
Induction of FOXF1 expression from day 0 of the culture also impaired endothelial differentiation as shown by a decrease in the frequency of CD144 + cells produced in the culture (Fig. 7C , upper panel, Dox d0-3). In contrast, an increase in the frequency of SMA + cells was observed (Fig. 7C lower panel) . When FOXF1 expression was induced at day 1 of the culture (Dox, d1-3), the endothelial potential was similar when compared to the noninduced culture condition but the frequency of SMA + cells remained high. These results suggest that the induction of FOXF1 expression in mesodermal progenitors impairs hematopoietic differentiation potential, while vascular differentiation potential toward endothelial and smooth muscle lineages is maintained or enhanced.
Given the profound and irreversible block in hematopoiesis induced by FOXF1, we next investigated whether FOXF1 acts in a cell-autonomous manner to shut down hematopoiesis or through the production of soluble factors as FOXF1 has been shown in vivo Development Accepted manuscript to control BMP4 transcription (Astorga and Carlsson, 2007) . For this purpose, FLK1 + Tomato-labeled cells (iTomato cells) were differentiated together with FLK1 + iFoxf1 cells in hemangioblast culture condition (Fig. 7D ). Upon addition of doxycycline, iTOMATO + cells were able to differentiate toward hematopoiesis at similar frequencies in the single or coculture (Fig 7E,F) are not yet observed in Foxf1 null embryos. While wt and heterozygous Foxf1::venus embryos had similar frequencies of primitive erythroid progenitors, Foxf1::venus homozygous null embryos had on average 6-fold more primitive erythroid progenitors (Fig.   7G ). Altogether, these data suggest that during gastrulation mesoderm specification toward hematopoiesis is negatively regulated by FOXF1.
DISCUSSION
The use of a knock-in VENUS reporter system allowed us for the first time to track, isolate and analyse mesodermal progenitors and their derivatives expressing the transcription factor FOXF1. Both in differentiating ESCs and in gastrulating embryos, we observed that 
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reporter allele have shown that all extra-embryonic mesoderm was derived from FLK1-expressing cells (Ema et al., 2006) . Altogether, these findings allow us to further dissect and understand the sequential commitment steps taking place during early mesoderm specification (Fig. 8) .
One of the most striking and surprising observations of our study is that of all the extra-embryonic mesoderm derivatives, hematopoiesis is the only one that does not express , 2011; Lee et al., 2008; Wareing et al., 2012b (Mahlapuu et al., 2001b) . This is in line with our observation that Foxf1 deficient embryos have a higher frequency of primitive erythroid progenitors than wt embryos.
In vitro, we observe that FOXF1::VENUS is expressed by a high frequency of cells in hemangioblast culture and differentiating EBs; by day 6 of differentiation EB cells either express CD41 and are hence committed to hematopoiesis or they express FOXF1 and might represent mesenchyme or mesothelium progenitors which rapidly give rise to smooth muscle upon further culture. It is interesting to note that in adult organism, the mesothelium retains remarkable progenitor characteristics with the ability to differentiate into myofibroblast, smooth muscle and endothelium upon injury or specific signals in organs such as lung (Que et al., 2008 ), heart (Zhou et al., 2008 or liver (Li et al., 2013; Rinkevich et al., 2012) . In line with this observations, FOXF1 has been shown later in life to be implicated in the regulation of visceral smooth muscle cells (Hoggatt et al., 2013) and the formation of embryonic vasculature (Ren et al., 2014) . The Foxf1::Venus ESC line will be helpful in future studies to dissect how Foxf1 expression is regulated during mesoderm specification. It was shown in vivo that Hedgehog signaling from the extra-embryonic endoderm is responsible for Foxf1 activation in the yolk sac mesoderm but not in the allantois (Astorga and Carlsson, 2007) , it will be interesting to define in vitro whether hedgehog inactivation prevents Foxf1 transcription in all or only a subset of mesodermal cells, possibly defining different type of mesoderm derivatives in vitro. During embryonic development, cell fate specification is orchestrated by tightly regulated molecular and cellular processes. Understanding how these processes occur in vivo is important from a fundamental perspective but it is also critical in helping us devise optimal protocols for the in vitro derivation of specific lineages from ESC to be used in the clinic for therapeutical applications.
MATERIALS AND METHODS
ESC and mouse lines: Inducible iFoxf1-2aGFP ESC line was established as previously described (Gandillet et al., 2009; Kyba et al., 2002 
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Cell culture and differentiation: ESC lines were maintained, differentiated and cultured in hemangioblast media as described (Lancrin et al., 2009a; Sroczynska et al., 2009 ). Where indicated, 1µg/ml of doxycycline was added to the culture medium. For reaggregation assay, sorted cells were seeded at 5 x 10 5 cells/ml in ultra-low attachment culture plates in embryoid bodies (EB) differentiation media. Populations sorted from E7.5 embryos were seeded onto irradiated OP9 stromal cells in hemogenic endothelium media (Mukouyama et al., 2000) supplemented with 1µg/ml osteopontin. For hematopoietic progenitor assays, cells were plated in 1% methylcellulose as previously described (Sroczynska et al., 2009 ).
Flow Cytometry: EBs or embryos were trypsinized (TryplE; Gibco) for 3 minutes, and the single-cell suspension was stained at +4C with a combination of antibodies. For intracellular staining, cells were fixed in PBS 2% para-formaldehyde and permeabilized in 0.5% saponin.
Antibodies were purchased from eBioscience (FLK1-bio, FLK1-APC, CD41-PE, CD41-PECy7, CD41-PacificBlue, CD45-PerCP-Cy5.5, CD140a-APC, CD144-APC, Tie2-PE, SApeCy7) or Sigma Aldrich (SMA-Cy3). Dead cells were excluded using Hoechst 33258 staining (Life technology). Cells were sorted using AriaII or Influx and analyzed on FACSCalibur, LSRII or LSRFortessa cytometer (BD Biosciences).
Immunohistochemistry: For tissue sections, embryos were fixed in PBS 4% paraformaldehyde, embedded in gelatin-sucrose and snap-freezed. Cryo-sections (7 μm) were blocked with 10% goat serum (DAKO), incubated with primary antibodies followed by fluorochrome-labelled species-specific secondary antibodies. Cultured cells were fixed in PBS 4% para-formaldehyde and blocked with serum prior to immunostaining. Whole-mount stainings were performed as previously described (Yokomizo et al., 2012) . Primary antibodies used were rat anti-mouse Flk1 (BD Pharmingen), anti-SMA-Cy3 (Sigma Aldrich)
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Gold antifade reagent with DAPI (Molecular Probes) and images were acquired using a Lowlight Zeiss Axiovert 200M system and an Andor iXon DU888+ camera. Whole mount samples were counterstained with DAPI and images were acquired using a Leica (SP8 MP CSU) Two Photon Confocal Microscope.
Gene expression analysis: Total RNA was extracted with RNeasy Plus Mini or Micro Kit (Qiagen), and was reverse-transcribed into cDNA with random hexamer oligonucleotides using Omniscript RT kit (Qiagen). Real-time PCR was performed on an ABI7900 (Applied Biosystems) using Universal ProbeLibrary System (Roche) with TaqMan Universal Master Mix (Applied Biosystems). Gene-specific oligonucleotide sequences and probes are available upon request. Expression data were calculated relative to -actin as 2 -Ct .
Single cell expression analysis:
Cell lysis, cDNA synthesis and specific gene target amplification was performed using the CellsDirect One-Step qRT-PCR kit (Invitrogen) as previously described (Moignard et al., 2015) . The assay mix contained a mix of primers for genes including foxf1 and β-actin from Sigma. Real-time PCR was performed as described under Gene expression analysis section.
Expression data were normalized to β-actin and plotted as 2 -ΔCt .
Microarray analysis: Total RNA was extracted and amplified using SuperAmp kit (Miltenyi). Gene expression analysis was performed using Affymetrix GeneChip Mouse exon 1.0 ST Array, and data were processed using Affymetrix Power Tools software package (Affymetrix) for RMA normalization and DABG detection. The expression level of a gene was calculated based on the median expression of its exonic probesets called present.
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Annotations and cross-mappings between probesets, exons and genes were obtained from Ensembl mouse genome build 70 using the R/BioConductor package annmap. Differential expression analysis was performed on gene-level data using the R/BioConductor package limma. Hierarchical clustering (Pearson correlation) was performed using GENE-E platform (www.broadinstitute.org/cancer/software/GENE-E/) and Function Annotation terms were obtained using Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems). Datasets are deposited in the GEO repository under accession number GSE66574.
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